Purdue Pleads Guilty to Felonies, Plea Deal Receives Criticism
Purdue Pharma pleads guilty to criminal charges for illegal marketing of the its highly addictive painkiller, OxyContin. Corporations often pay penalties and fines for wrongdoing, yet criminal charges are rare. These charges include felony charges of defrauding federal health agencies and violating anti-kickback laws. The company also paid civil penalties for violating the False Claims […]
Effect of COVID-19 Pandemic on Opioid Crisis and Litigation
As the COVID-19 pandemic continues to plague America, worsening the opioid crisis that has plagued the nation for decades, litigation to recoup the cost of fighting the opioid crisis has stalled. While local and state governments await desperately needs funds to continue to provide services in support of those plagued by addiction to opioids, the […]
Lack of Pharmacy Oversight Contributed to Opioid Crisis
The opioid crisis has highlighted problems with Pennsylvania’s prescription drug monitoring system. Over the past few years the Pennsylvania Department of Health has worked on a statewide database for monitoring schedule II – V controlled substances. Lack of oversight of pharmacist dispensed drugs played a roll in fueling the opioid crisis. Several large pharmacy chains, […]
State and Local Lawmakers Goals Conflict in Opioid Litigation
Plaintiffs’ in the multi-district litigation, which consisting of more than 2,500 cities and counties, suing opioid manufacturers and distributors for their role in the opioid crisis find they have conflicting goals with state lawmakers in the ongoing opioid litigation. State attorneys general are adamant on taking drug manufacturers and distributors to trial in hopes of winning a […]
